The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 2009; 166:450-459
(published online March 16, 2009; doi: 10.1176/appi.ajp.2008.08101484)
© 2009 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Data Supplement
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Maldonado-Avilés, J. G.
* Articles by Lewis, D. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Maldonado-Avilés, J. G.
* Articles by Lewis, D. A.
Related Collections
* Neurotransmitters
* Schizophrenia Spectrum Disorders

Altered Markers of Tonic Inhibition in the Dorsolateral Prefrontal Cortex of Subjects With Schizophrenia

Jaime G. Maldonado-Avilés, Ph.D., Allison A. Curley, B.A., Takanori Hashimoto, M.D., Ph.D., A. Leslie Morrow, Ph.D., Amy J. Ramsey, Ph.D., Patricio O’Donnell, M.D., Ph.D., David W. Volk, M.D., Ph.D., and David A. Lewis, M.D.

OBJECTIVE: Cognitive impairments in schizophrenia are associated with lower expression of markers of {gamma}-aminobutyric acid (GABA) synthesis in the prefrontal cortex. The effects of GABA are mediated by GABAA receptors that mediate either phasic or tonic inhibition. The authors assessed the expression of GABAA receptor {alpha}4 and {delta} subunits, which coassemble to form receptors mediating tonic inhibition, in schizophrenia. METHOD: The authors used in situ hybridization to quantify expression patterns of GABAA receptor {alpha}4 and {delta} subunits in prefrontal cortex from 23 matched pairs of schizophrenia and comparison subjects. RESULTS: Levels of {delta} mRNA were significantly lower in schizophrenia subjects regardless of medication use, whereas {alpha}4 mRNA levels were lower only in subjects with schizophrenia receiving certain medications at the time of death. To understand the nature of this unexpected dissociation between {alpha}4 and {delta} subunit expression in schizophrenia, the authors used similar methods to quantify {alpha}4 and {delta} mRNA levels in multiple animal models. During postnatal development of monkey prefrontal cortex, levels of {alpha}4 mRNA decreased, whereas {delta} mRNA levels increased. In addition, {delta} mRNA levels, but not {alpha}4 mRNA levels, were lower in the medial frontal cortex of mice with a genetic deletion of the GABAA receptor {alpha}1 subunit, and neither {delta} nor {alpha}4 mRNA levels were altered in rodent models of altered excitatory neurotransmission. CONCLUSIONS: Since GABAA receptor {alpha}1 subunits also have lower mRNA levels in schizophrenia, show increased expression with age in monkey prefrontal cortex, and can coassemble with {delta} subunits to form functional GABAA receptors, lower {delta} mRNA levels in schizophrenia might reflect a reduced number of {alpha}1βx{delta} GABAA receptors that could contribute to deficient tonic inhibition and prefrontal cortical dysfunction in schizophrenia.




This article has been cited by other articles:


Home page
JWatch PsychiatryHome page
What Interferes with Inhibitory Functions in the Prefrontal Cortex in Schizophrenia?
Journal Watch Psychiatry, May 4, 2009; 2009(504): 4 - 4.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2009 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org